Investment Thesis
AEHR exhibits severe operational distress with negative operating margins of -41.8% and negative free cash flow of -3.3M despite modest revenue of $20.9M. The company is burning cash operationally while making capital investments, indicating fundamental business model challenges that are not being offset by scale or efficiency improvements. While the balance sheet remains fortress-like with minimal debt and $30.8M in cash, the persistent unprofitability and negative cash generation trajectory pose existential risks if operational losses continue.
AEHR Strengths
- Fortress balance sheet with $30.8M cash and zero long-term debt providing 13+ months of runway at current burn rate
- Exceptional liquidity position with current ratio of 10.62x enabling financial flexibility
- Maintained moderate gross margin of 30% indicating product pricing power despite operational challenges
AEHR Risks
- Severe profitability crisis with negative operating margin of -41.8% and net loss of -$5.3M indicating structural business model problems
- Negative free cash flow of -$3.3M despite near-zero revenue growth suggesting operational efficiency is deteriorating rather than improving
- EPS deterioration of -111.6% YoY and sustained losses indicate company is in distressed state rather than temporary downturn phase
- High insider trading activity (30 Form 4 filings in 90 days) may signal uncertainty or opportunistic equity liquidation
Key Metrics to Watch
- Operating cash flow trajectory and path to positive FCF generation
- Revenue growth acceleration and corresponding operating leverage improvements
- Operating margin recovery toward break-even and positive territory
- Cash burn rate and remaining runway before liquidity crisis
AEHR Financial Metrics
AEHR Profitability Ratios
AEHR Balance Sheet & Liquidity
AEHR 5-Year Financial Trend
5-Year Trend Summary: AEHR TEST SYSTEMS's revenue has grown significantly by 197% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.50 reflects profitable operations.
AEHR Growth Metrics (YoY)
AEHR Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $9.9M | -$368.0K | $-0.01 |
| Q1 2026 | $11.0M | $660.0K | $0.02 |
| Q3 2025 | $7.6M | -$643.0K | $-0.02 |
| Q2 2025 | $13.5M | -$368.0K | $-0.01 |
| Q1 2025 | $13.1M | $660.0K | $0.02 |
| Q3 2024 | $7.6M | -$1.5M | $-0.05 |
| Q2 2024 | $14.8M | $3.7M | $0.13 |
| Q1 2024 | $10.7M | $589.0K | $0.02 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AEHR Capital Allocation
AEHR SEC Filings
Access official SEC EDGAR filings for AEHR TEST SYSTEMS (CIK: 0001040470)